Skip to Content

Juvederm Approval History

FDA Approved: Yes (First approved June 2, 2006)
Brand name: Juvederm
Generic name: dermal filler
Company: Allergan, Inc.
Treatment for: Facial Rejuvenation

Juvéderm is a hyaluronic acid dermal filler indicated for the correction of facial wrinkles and folds.

  • Juvéderm Voluma XC injectable gel is for deep injection in the cheek area to correct age-related volume loss in adults over 21.
  • Juvéderm Vollure XC injectable gel is for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over 21.
  • Juvéderm XC injectable gel is for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
  • Juvéderm Ultra XC is for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
  • Juvéderm Volbella XC injectable gel is for injection into the lips for lip augmentation and for correction of perioral lines in adults over the age of 21.

Development History and FDA Approval Process for Juvederm

DateArticle
Sep  3, 2019Approval FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula
Mar 20, 2017Approval FDA Approves Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds in Adults
Jun  1, 2016Approval FDA Approves Juvéderm Volbella XC for Use in Lips and Perioral Rhytids
Oct  1, 2015Approval FDA Approves Juvéderm Ultra XC for Lip Augmentation
Oct 23, 2013Approval FDA Approves Juvéderm Voluma XC to Correct Age-Related Volume Loss in the Cheek Area
Feb  1, 2010Approval FDA Approves Juvéderm XC Containing Lidocaine to Correct Facial Wrinkles and Folds
Jun  5, 2006Approval Juvederm Allergan, Inc. - Treatment for Facial Wrinkles and Folds

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide